Archived documents
Documents past their public comment period for Pharmaceutical Policy.
PSG_020911 - Draft Guidance on Beclomethasone Dipropionate
0 comments
Analysis in progress
Top issues in comments
PSG_216579 - Draft Guidance on Budesonide; Formoterol Fumarate
0 comments
Analysis in progress
Top issues in comments
PSG_021929 - Draft Guidance on Budesonide; Formoterol Fumarate Dihydrate
0 comments
Analysis in progress
Top issues in comments
PSG_212122 - Draft Guidance on Budesonide; Formoterol Fumarate; Glycopyrrolate
0 comments
Analysis in progress
Top issues in comments
PSG_209819 - Draft Guidance on Buprenorphine
0 comments
Analysis in progress
Top issues in comments
PSG_215499 - Draft Guidance on Cabotegravir
0 comments
Analysis in progress
Top issues in comments
PSG_212888 - Draft Guidance on Cabotegravir; Rilpivirine
0 comments
Analysis in progress
Top issues in comments
PSG_219921 - Draft Guidance on Carboplatin
0 comments
Analysis in progress
Top issues in comments
PSG_050406 - Draft Guidance on Cephalexin
0 comments
Analysis in progress
Top issues in comments
PSG_021658 - Draft Guidance on Ciclesonide
0 comments
Analysis in progress
Top issues in comments
PSG_050767 - Draft Guidance on Clindamycin Phosphate
0 comments
Analysis in progress
Top issues in comments
PSG_213491 - Draft Guidance on Cysteamine Bitartrate
0 comments
Analysis in progress
Top issues in comments